KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Minority Interest (2020 - 2025)

Historic Minority Interest for AbbVie (ABBV) over the last 6 years, with Q3 2025 value amounting to $43.0 million.

  • AbbVie's Minority Interest rose 1025.64% to $43.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year increase of 1025.64%. This contributed to the annual value of $39.0 million for FY2024, which is 540.54% up from last year.
  • Per AbbVie's latest filing, its Minority Interest stood at $43.0 million for Q3 2025, which was up 1025.64% from $45.0 million recorded in Q2 2025.
  • AbbVie's Minority Interest's 5-year high stood at $45.0 million during Q2 2025, with a 5-year trough of $23.0 million in Q1 2021.
  • For the 5-year period, AbbVie's Minority Interest averaged around $34.7 million, with its median value being $35.0 million (2022).
  • As far as peak fluctuations go, AbbVie's Minority Interest surged by 4210.53% in 2021, and later plummeted by 857.14% in 2023.
  • Quarter analysis of 5 years shows AbbVie's Minority Interest stood at $28.0 million in 2021, then increased by 17.86% to $33.0 million in 2022, then grew by 12.12% to $37.0 million in 2023, then increased by 5.41% to $39.0 million in 2024, then increased by 10.26% to $43.0 million in 2025.
  • Its Minority Interest stands at $43.0 million for Q3 2025, versus $45.0 million for Q2 2025 and $42.0 million for Q1 2025.